Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].

Deutsche medizinische Wochenschrift (1946) - 8 Apr 2004

Wuttke H, Rau T, Eschenhagen T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Benzopyrans
Share to Biotransformation
Share to Carbazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Ethanolamines

Share to Metoprolol

Share to Propanolamines

Source

Identifiers

PMID: 15054690
DOI: 10.1055/s-2004-823030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].PMID 15054690Read ↗

[Genetic polymorphism of drug metabolizing enzymes].Semantic proximity Read ↗

The clinical role of genetic polymorphisms in drug-metabolizing enzymesSemantic proximity Read ↗

[Pharmacogenomics. What is relevant for the internal medicine specialist?].Semantic proximity Read ↗

Genetic polymorphisms of drug metabolism.Semantic proximity Read ↗

The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Semantic proximity Read ↗

[Polymorphism of enzymes involved in drug metabolism: gene structure and enzymatic activity].Semantic proximity Read ↗

[Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].Semantic proximity Read ↗

Pharmacogenetic factors affecting β-blocker metabolism and response.Semantic proximity Read ↗

The impact of genetic polymorphisms in risk assessment of drugs.Semantic proximity Read ↗

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.Semantic proximity Read ↗

Genetic polymorphisms influencing antihypertensive drug responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.